Principal Investigators

    Marie Öhman


    Stockholm University

    Contact information of lead PI



    Title of project or programme

    RNA editing and its functional consequences in the human brain

    Source of funding information

    Swedish Research Council

    Total sum awarded (Euro)

    € 505,985

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Motor neurone diseases


    Research Abstract

    High throughput (HTP) sequencing analysis have revealed that adenosine to inosine RNA editing is a more common event in the human transcriptome than previously anticipated. A-to-I editing have the potential to diversify the code of mRNAs since I is read as guanosine during translation. However, the functional consequences of many of these RNA editing events are still unknown. We will analyze human specific RNA editing and determine their role in brain function. Using RNA-Seq we will investigate if A-to-I editing can induce alternative splicing and polyadenylation, an event that previously has been ignored. We will do this by analyzing altered RNA processing in mouse brain deficient for the editing enzyme. Premature polyadenylation caused by editing will also be analyzed in the glutamate transporter EAAT2. Altered editing of EAAT2 has been suggested as part of the cause of motor neuron death in patients with amyotrophic lateral sclerosis (ALS). The cause of the aberrant editing in ALS patients will be investigated. Finally, we want to continue our analysis on the role of RNA editing in the regulation of the GABA-A receptor during brain development. Transgenic mice with or without the ability to edit the receptor will be made and analyzed for the possibility of gating deficiencies in dopamine neurons. By analyzing these modifications in the human transcriptome we have a chance to solve some of these enigmas and understand the molecular cause of several neurological disorders.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Sweden
Diseases: Motor neurone diseases
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF